- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03037112
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Significance: Antibiotic overuse and misuse contribute to the development of antibiotic resistant infections that kill at least 23,000 Americans and cause an additional 2 million infections annually. If left unchecked, antibiotic resistant infections are estimated to cause 10 million deaths worldwide by 2050. Antibiotic associated adverse drug reactions (e.g., rash, diarrhea, nausea, and vomiting) also result in over 140,000 Emergency Department visits annually.
The majority of all antibiotic prescribing occurs in outpatient settings where children receive 49 million prescriptions annually. Over 70% of these are for respiratory infections and nearly 8.5 million of these prescriptions are inappropriate (i.e., either an unnecessary broad-spectrum antibiotic or to treat a viral illness). There are many factors that lead to overprescribing, but chief among them is inadequate parent-provider communication.
Innovation: This study is the first US multi-site randomized controlled trial comparing the effectiveness an education vs. communication skills provider intervention to stimulate high quality parent-provider communication and judicious use of antibiotics.
Approach: 1,600 eligible parents (or caregivers) of children between the ages of 1 and 5 will be enrolled and exposed to one of the interventions based on the provider they see for their visit. English and Spanish speaking parents will be recruited from the Children's Mercy Hospital Primary Care Clinic (CMH PCC) in Kansas City, Missouri and the Heartland Primary Care Clinics in Kansas City, KS and Lenexa, KS. Parents in both arms will receive identical brief negatively behavioral framed antibiotic education via tablet computers. Providers will be randomized to the parent-provider education or communication skills intervention arm and trained accordingly. The primary outcome is rate of inappropriate antibiotic prescribing. Secondary outcomes are parental ratings of shared decision-making and satisfaction, re-visits and adverse drug reactions. Data will be collected via a tablet computer administered RedCap survey administered in the exam room prior and immediately following the child's visit. Additional data will be garnered from the medical record (antibiotic prescribing) and a 2-week follow-up telephone call with parents (re-visits and adverse drug reactions).
Public Health Impact: This study could have significant public health implications and meet the goals outlined in the 2014 Executive Order on Combating Antibiotic Resistance, which seeks to slow the emergence of resistant bacteria and prevent the spread of resistant infections through the judicious and appropriate use of antibiotics.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Kansas
-
Kansas City, Kansas, Spojené státy, 66109
- Heartland Primary Care
-
Lenexa, Kansas, Spojené státy, 66227
- Heartland Primary Care
-
-
Missouri
-
Kansas City, Missouri, Spojené státy, 64111
- Children's Mercy Pediatric Care Clinic
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria: \
- Parent or guardian of a child 1-5 years of age with suspected respiratory tract infection who are English or Spanish speaking
Exclusion Criteria:
- Parents of children who require hospitalization
- Received antibiotics in the last 30 days
- Have concurrent bacterial infection, an immune compromising condition or chronic medical condition
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Výzkum zdravotnických služeb
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Aktivní komparátor: Education
All providers will receive identical training on the appropriate prescribing of antibiotics for ARTIs in a 20 minute presentation.
Follow up refresher video clips will also be available for all providers to view at their convenience throughout the study.
Parents in both arms will receive identical high quality education on the pros and cons of antibiotics and tips for communicating with their provider.
|
The first intervention is an educational intervention regarding appropriate diagnosis and treatment of common respiratory infections.
This education will be delivered in an interactive lecture format for providers with follow up short informational video clips available over the course of the project.
|
Aktivní komparátor: Communication Skills
Providers randomized to the communication intervention will receive additional training on communication skills in a 40 minute communication skills training session.
This training session will include good and bad communication examples, training on positive and negative behavioral framing, and education regarding key drivers of patient satisfaction.
|
The second intervention is an education plus communication skills training intervention.
This training session will include identical antibiotic education training, good and bad communication examples, training on negative behavioral framing, and education regarding key drivers of patient satisfaction.
Additionally providers will be informed of parent's desire for antibiotics rating prior to their consultation with the patient.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Inappropriate antibiotic use
Časové okno: 18 months
|
Patient medical records will be reviewed 2 weeks after the visit to determine the clinical diagnosis and whether or not antibiotics were given.
Determination will be made regarding the appropriateness of the diagnosis and prescribing using current clinical practice guidelines.
|
18 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Revisits
Časové okno: 18 months
|
All parents will be called 2 weeks following the initial visit to determine if any revisits to the same office or to another health care facility were made after the initial visit for either clinical worsening or lack of clinical improvement, or due to an adverse drug reaction.
|
18 months
|
Adverse drug reactions
Časové okno: 18 months
|
All parents will be called 2 weeks following the visit to determine if the patient developed an adverse drug reaction to antibiotics.
|
18 months
|
Shared decision-making
Časové okno: 18 months
|
Parents will rate the quality of the shared decision-making using validated survey instruments
|
18 months
|
Parent Satisfaction with visit
Časové okno: 18 months
|
Parents will rate the their satisfaction with the visit using validated measures.
|
18 months
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Jason G. Newland, MD, Washington University School of Medicine
- Vrchní vyšetřovatel: Kathy Goggin, PhD, Childrens Mercy Hospital
Publikace a užitečné odkazy
Obecné publikace
- Goggin K, Hurley EA, Bradley-Ewing A, Bickford C, Lee BR, Pina K, De Miranda ED, Mackenzie A, Yu D, Weltmer K, Linnemayr S, Butler CC, Miller M, Newland JG, Myers AL. Reductions in Parent Interest in Receiving Antibiotics following a 90-Second Video Intervention in Outpatient Pediatric Clinics. J Pediatr. 2020 Oct;225:138-145.e1. doi: 10.1016/j.jpeds.2020.06.027. Epub 2020 Jun 15.
- Goggin K, Bradley-Ewing A, Myers AL, Lee BR, Hurley EA, Delay KB, Schlachter S, Ramphal A, Pina K, Yu D, Weltmer K, Linnemayr S, Butler CC, Newland JG. Protocol for a randomised trial of higher versus lower intensity patient-provider communication interventions to reduce antibiotic misuse in two paediatric ambulatory clinics in the USA. BMJ Open. 2018 May 9;8(5):e020981. doi: 10.1136/bmjopen-2017-020981.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další identifikační čísla studie
- PCORI150731759
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Education
-
US Department of Veterans AffairsIndiana University School of MedicineDokončeno
-
Aveiro UniversityNeznámýBolest krkuPortugalsko
-
Selcuk UniversityDokončenoPraxe založená na důkazechKrocan
-
University of South FloridaNational Cancer Institute (NCI)StaženoDětská rakovinaSpojené státy
-
Scripps Whittier Diabetes InstituteNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); San... a další spolupracovníciDokončenoCukrovka typu 2Spojené státy
-
National Healthcare Group, SingaporeTan Tock Seng HospitalDokončenoDiabetičtí pacienti, gamifikace, diabetická výchovaSingapur
-
University of NottinghamDokončenoDiabetes mellitus, typ 2 | Zdravotní chováníJordán
-
Medical College of WisconsinAktivní, ne náborCukrovka typu 2Spojené státy
-
VA Office of Research and DevelopmentDokončeno
-
Grand Valley State UniversityMichigan State UniversityDokončenoDemence | Alzheimerova nemoc | Alzheimerova demence | Poruchy paměti související s věkemSpojené státy